A molecular epidemiology study based on VP2 gene sequences reveals that a new genotype of infectious bursal disease virus is dominantly prevalent in Italy
暂无分享,去创建一个
M. Cecchinato | P. Pesente | M. Bonci | D. Giovanardi | C. Lupini | E. Catelli | E. Morandini | V. Felice | G. Rossi
[1] M. Cecchinato,et al. Reversion to virulence of a subtype B avian metapneumovirus vaccine: is it time for regulators to require availability of vaccine progenitors? , 2014, Vaccine.
[2] E. Ndegwa,et al. Comparison of Vaccine Subpopulation Selection, Viral Loads, Vaccine Virus Persistence in Trachea and Cloaca, and Mucosal Antibody Responses After Vaccination with Two Different Arkansas Delmarva Poultry Industry–Derived Infectious Bronchitis Virus Vaccines , 2014, Avian diseases.
[3] S. Stoute,et al. Molecular Evidence for a Geographically Restricted Population of Infectious Bursal Disease Viruses , 2013, Avian diseases.
[4] D. Jackwood. Molecular Epidemiologic Evidence of Homologous Recombination in Infectious Bursal Disease Viruses , 2012, Avian diseases.
[5] Ramón Doallo,et al. CircadiOmics: integrating circadian genomics, transcriptomics, proteomics and metabolomics , 2012, Nature Methods.
[6] M. Cecchinato,et al. A turkey rhinotracheitis outbreak caused by the environmental spread of a vaccine-derived avian metapneumovirus , 2011, Avian pathology : journal of the W.V.P.A.
[7] Ramón Doallo,et al. ProtTest 3: fast selection of best-fit models of protein evolution , 2011, Bioinform..
[8] D. Jackwood,et al. Amino acids contributing to antigenic drift in the infectious bursal disease Birnavirus (IBDV). , 2011, Virology.
[9] A. Moreno,et al. Epidemic of Infectious Laryngotracheitis in Italy: Characterization of Virus Isolates by PCR–Restriction Fragment Length Polymorphism and Sequence Analysis , 2010, Avian diseases.
[10] M. Cecchinato,et al. Avian metapneumovirus (AMPV) attachment protein involvement in probable virus evolution concurrent with mass live vaccine introduction. , 2010, Veterinary microbiology.
[11] O. Gascuel,et al. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. , 2010, Systematic biology.
[12] M. Cecchinato,et al. Field avian metapneumovirus evolution avoiding vaccine induced immunity. , 2010, Vaccine.
[13] Maricarmen García,et al. Pathogenicity and growth characteristics of selected infectious laryngotracheitis virus strains from the United States , 2009, Avian pathology : journal of the W.V.P.A.
[14] B. Sreedevi,et al. Studies on naturally occurring infectious bursal disease viruses suggest that a single amino acid substitution at position 253 in VP2 increases pathogenicity. , 2008, Virology.
[15] Mark Johnson,et al. NCBI BLAST: a better web interface , 2008, Nucleic Acids Res..
[16] L. Dufour-Zavala. A laboratory manual for the isolation, identification and characterization of avian pathogens , 2008 .
[17] G. Tosi,et al. Genetic and Antigenic Characterization of Infectious Bursal Disease Viruses Isolated in Italy During the Period 2002–2005 , 2007, Avian diseases.
[18] Rodrigo Lopez,et al. Clustal W and Clustal X version 2.0 , 2007, Bioinform..
[19] J. D. de Wit,et al. Molecular Characteristics of Infectious Bursal Disease Viruses from Asymptomatic Broiler Flocks in Europe , 2006, Avian diseases.
[20] M. Cecchinato,et al. Demonstration of loss of attenuation and extended field persistence of a live avian metapneumovirus vaccine. , 2006, Vaccine.
[21] M. Islam,et al. Reversion of molecularly engineered, partially attenuated, very virulent infectious bursal disease virus during infection of commercial chickens , 2004, Avian Pathology.
[22] R. Heckert,et al. Molecular Determinants of Virulence, Cell Tropism, and Pathogenic Phenotype of Infectious Bursal Disease Virus , 2001, Journal of Virology.
[23] E. Mundt. Tissue culture infectivity of different strains of infectious bursal disease virus is determined by distinct amino acids in VP2. , 1999, The Journal of general virology.
[24] A. A. Gusev,et al. [Comparative analysis of the VP2 variable region of the gene from infectious bursal disease virus isolates]. , 1998, Molekuliarnaia genetika, mikrobiologiia i virusologiia.
[25] F. Kibenge,et al. Infectious bursal disease virus: a review of molecular basis for variations in antigenicity and virulence. , 1997, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.
[26] P. Woolcock,et al. Infectious bursal disease. , 1994 .
[27] A. Azad,et al. Sequence analysis and expression of the host-protective immunogen VP2 of a variant strain of infectious bursal disease virus which can circumvent vaccination with standard type I strains. , 1991, The Journal of general virology.
[28] J. Stuart,et al. Outbreak of virulent infectious bursal disease in East Anglia , 1989, Veterinary Record.
[29] R. Russell,et al. Biochemistry and immunology of infectious bursal disease virus. , 1988, The Journal of general virology.